Morbidity patterns among low-income wheezing infants

Mary D Klinnert1, Marcella R Price, Andrew H Liu

  • 1Department of Pediatrics, National Jewish Medical and Research Center, Denver, Colorado 80206, USA. klinnertm@njc.org

Pediatrics
|July 3, 2003
PubMed

Insights

Infant wheezing illness morbidity is linked to biological factors like RSV and allergens, as well as social factors such as single-parent status and smoking. Caregiver anxiety also impacts perceived illness severity.

Area of Science:

  • Pediatric respiratory health
  • Environmental health
  • Public health

Background:

  • Infant wheezing illness contributes significantly to childhood morbidity.
  • Understanding risk factors for infant wheezing is crucial for early intervention and asthma prevention.
  • Socioeconomic and environmental factors play a role in infant respiratory health outcomes.

Purpose of the Study:

  • To describe morbidity from wheezing illness in low-income infants.
  • To examine biological, environmental, and psychosocial factors associated with wheezing illness morbidity.
  • To identify correlates of healthcare utilization for infant wheezing.

Main Methods:

  • Evaluated infants aged 9-24 months at risk for asthma.
  • Collected data on biological, environmental, and psychosocial factors at baseline.
  • Assessed morbidity using caregiver reports, quality of life surveys, and medical records (hospitalizations, emergency department visits).

Main Results:

  • 46% of infants hospitalized, 59% had multiple emergency department visits for wheezing.
  • Foreign-born Hispanic families had more emergency department visits but reported less severity.
  • Biological factors (RSV, IgE, cockroach allergen) linked to hospitalizations; social factors (single parent, smokers) linked to emergency department visits.

Conclusions:

  • Ethnic and immigrant status significantly impacts infant wheezing morbidity.
  • Morbidity is associated with respiratory infections, allergic processes, and social variables.
  • Psychosocial factors, including caregiver anxiety, correlate with reported illness severity.
Abstract

Related Concept Videos

Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...